MDxHealth
Oppenheimer, BTIG Initiate Coverage of MDxHealth at Outperform, Buy
Oppenheimer set an $18 price target for the company's shares, and BTIG set a $15 price target.
In Brief This Week: MDxHealth, Co-Diagnostics, HTG Molecular Diagnostics, Immunovia, and More
News items for the in vitro diagnostics industry for the week of Nov. 8, 2021.
MDxHealth Prices IPO of American Depositary Shares
The diagnostics company is offering 3.75 million ADSs at $12 per share and is hoping to raise gross proceeds of $45 million.
MDxHealth Q3 Revenues Grow 23 Percent
The firm's services revenues for Q3 rose 23 percent, and test volume for its ConfirmMDx assay rose 5 percent, but volume for its SelectMDx test fell 1 percent.
MDxHealth Files for IPO of American Depositary Shares
The company, which confidentially submitted a draft registration statement to the SEC in September, has now publicly filed for listing on the Nasdaq.
Mar 3, 2021
MDxHealth 2020 Revenues Up 57 Percent
Oct 21, 2020
MDxHealth Q3 2020 Revenues Drop 6 Percent
Feb 26, 2020
MDxHealth 2019 Revenues Fall 58 Percent
Aug 29, 2019
MDxHealth H1 2019 Revenues Fall 37 Percent
Apr 24, 2019